Skip to content
OpenCapital
Get started

OS Therapies OSTX Conversion Price Percentage

Conversion Price Percentage at other companies

KEE
Keel Infrastructure Corp. Common StockKEEL
130%—
KEE
Keel Infrastructure Corp. Common StockKEEL
30%—
Evommune logo
Evommune EVMN
120%—
Evommune logo
Evommune EVMN
50%—
PCS
Perceptive Capital SolutionsPCSC
20%0.0pp
Evommune logo
Evommune EVMN
25%—

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M—
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K—
Free cash flow-$3.7M—

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M—

Returns & leverage

See full
Return on equity470%—
Debt / equity-1.8×—
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:ConversionPricePercentage.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's conversion price percentage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's conversion price percentage?
OS Therapies (OSTX) reported conversion price percentage of 90% in Q4 2025.
What does conversion price percentage mean?
This metric measures the ratio or percentage relationship between the conversion price of convertible securities and the underlying common stock price. It is used to evaluate the likelihood of debt or preferred equity converting into common equity, which informs the potential for future shareholder dilution. Monitoring this percentage helps investors understand the company's capital structure flexibility and the risk profile of its outstanding convertible instruments.